Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3048 |
|
| Actual shortage: | 226 (7%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2019-07-12 | 2019-08-17 | 89158 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-08-28 | 2020-02-19 | 92522 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-11-30 | 2019-02-08 | 68218 |
| APO-FINASTERIDE | 5MG | TABLET | Resolved | 2019-09-12 | 2019-10-01 | 93671 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-10-15 | 2021-11-29 | 147292 |
| APO-FUROSEMIDE | 20MG | TABLET | Resolved | 2018-07-31 | 2018-10-11 | 56983 |
| APO-FUROSEMIDE | 40MG | TABLET | Resolved | 2018-07-16 | 2018-09-11 | 55839 |
| APO-FUROSEMIDE | 80MG | TABLET | Resolved | 2017-03-10 | 2017-06-05 | 327 |
| APO-FUROSEMIDE | 80MG | TABLET | Resolved | 2018-08-09 | 2018-11-03 | 57789 |
| APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-10-08 | 2021-10-29 | 146904 |
| APO GLYBURIDE TAB 5MG | 5MG | TABLET | Resolved | 2017-07-26 | 2017-10-05 | 17237 |
| APO-HALOPERIDOL LIQ 2MG/ML | 2MG | SOLUTION | Actual shortage | 2017-08-13 | 2017-10-05 | 18957 |
| APO HALOPERIDOL TAB 0.5MG | .5MG | TABLET | Actual shortage | 2017-08-11 | 2017-10-05 | 18760 |
| APO HALOPERIDOL TAB 1MG | 1MG | TABLET | Actual shortage | 2017-08-11 | 2017-10-05 | 18763 |
| APO-HYDROCHLOROTHIAZIDE | 100MG | TABLET | Resolved | 2017-03-10 | 2019-11-26 | 330 |
| APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Resolved | 2018-04-24 | 2018-07-03 | 47102 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2018-11-16 | 2018-12-08 | 67023 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2019-03-20 | 2020-04-01 | 79042 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2018-03-13 | 2018-05-09 | 42694 |
| APO-INDOMETHACIN | 25MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18961 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60766 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60772 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2019-02-05 | 60778 |
| APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
| APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
| APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-SIMVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60790 |
| APO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-11-19 | 60793 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
| APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61033 |
| APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
| APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |